StockIQStockIQ.tech

Replimune Group, Inc. (REPL) Stock Analysis

--

Free AI-powered analysis and research for Replimune Group, Inc. stock

Sector: Healthcare

Full REPL report

Replimune Group, Inc. (REPL) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze REPL Now โ†’

๐Ÿ“ฐ Latest Update

Wall Street Analysts Believe Replimune Group (REPL) Could Rally 26.8%: Here's is How to Trade

Replimune Group, Inc. (REPL) has seen a 34.7% increase in its stock price over the past month, closing at $17.61. Wall Street analysts suggest a potential upside of 26.8%, with a mean price target of $22.33, although estimates vary significantly. The article highlights that while analysts show optimism regarding REPL's earnings prospects, investors should approach price targets with skepticism, as they may not reliably indicate future stock performance.

Read full article โ†’

History

People also watch

ABBV
AbbVie Inc.
--
ELV
Elevance Health Inc.
--
LLY
Eli Lilly and Company
--
RIGL
Rigel Pharmaceuticals, Inc.
--
HRMY
Harmony Biosciences Holdings, Inc.
--